Pharmafile Logo
Pharmafocus logo
Advanced Search

R&D

Showing 15 posts of 146 posts found.

Scinopharm Taiwan to build injectable drug facility

July 3, 2012
Manufacturing and Production CMO, HPAPI, R&D, Scinopharm Taiwan

Contract manufacturing organisation Scinopharm Taiwan has said it plans to invest around $37.6 million in a new high-potency active pharmaceutical …

News
EMA image

EMA publishes updated diabetes guidelines

July 2, 2012
Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda

The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …

News
Witty image

Witty warns EU leaders over pricing

June 27, 2012
Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing

Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …

News

Roche cuts 1,000 R&D jobs

June 27, 2012
Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …

News

GSK partners with Cambridge University

June 18, 2012
Research and Development, Sales and Marketing ABPI, Cambridge, GSK, R&D

The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …

News

Merck Serono staff may strike over Geneva HQ closure

June 6, 2012
Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D

Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …

News

Europe’s CMO market set to double by 2018, says F&S

May 30, 2012
Manufacturing and Production CMO, Europe, F&S, R&D, Taylor, manufacturing

The European market for pharmaceutical contract manufacturing will double from a value of around $10 billion last year to almost …

News

GSK starts combination trial for melanoma

May 30, 2012
Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma

GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs.  The firm will combine dabrafenib, its …

News

Pharma R&D model no help to developing countries

May 22, 2012
Research and Development, Sales and Marketing HIV, MSF, Médecins Sans Frontières, R&D

Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …

News

UCB signs new epilepsy research pact with Imperial

May 21, 2012
Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy

UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …

News

Merck KGaA sets out savings target as staff threaten to strike

May 15, 2012
Research and Development, Sales and Marketing Merck KGaA, R&D, Serono, cuts

Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …

News
GSK picture

GlaxoSmithKline to acquire Cellzome for £61 million

May 15, 2012
Research and Development, Sales and Marketing Cellzome, Domantis, GSK, R&D

GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company.  GSK will acquire those shares …

News

Teva appoints new president of R&D

May 9, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Hayden, R&D, Teva

Teva has appointed Dr Michael Hayden as its new president of global R&D and chief scientific officer at the firm’s …

Appointment
takeda_tokyo_hq

Takeda to buy gout specialist URL Pharma for $800m

April 16, 2012
Research and Development, Sales and Marketing R&D, Takeda, acquisition, gout

Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid.  …

News
Steve Yang

Innovating in China’s pharma market

April 12, 2012
Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets

The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026